Merck Canada Revenue and Competitors
Estimated Revenue & Valuation
- Merck Canada's estimated annual revenue is currently $104.3M per year.
- Merck Canada's estimated revenue per employee is $201,000
Employee Data
- Merck Canada has 519 Employees.
- Merck Canada grew their employee count by 22% last year.
Merck Canada's People
| Name | Title | Email/Phone |
|---|
Merck Canada Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.2M | 16 | 7% | N/A | N/A |
#2 | $30.2M | 150 | 1% | N/A | N/A |
#3 | $10.7M | 100 | 5% | $39.7M | N/A |
#4 | $104.3M | 519 | 22% | N/A | N/A |
#5 | $47.8M | 238 | N/A | N/A | N/A |
#6 | $15.5M | 77 | 5% | N/A | N/A |
#7 | $395.8M | 1969 | 7% | N/A | N/A |
#8 | $187.3M | 932 | 6% | N/A | N/A |
#9 | $361.6M | 1799 | 6% | N/A | N/A |
#10 | $27.5M | 137 | 0% | N/A | N/A |
What Is Merck Canada?
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. \n\nFor over 130 years, we have brought hope to humanity through the development of important medicines and vaccines. \n\nWe aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. \n\nWe foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities. \n\nThis page is intended for the residents of Canada. \n\nRead our Community Engagement Guidelines, visit https://bit.ly/3OWyUJZ
keywords:N/A
N/A
Total Funding
519
Number of Employees
$104.3M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Kirkland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $204.1M | 563 | -3% | N/A |
#2 | $163.2M | 584 | -29% | $44.1M |
#3 | $243.9M | 591 | -7% | $1.3B |
#4 | $111.3M | 614 | 5% | N/A |
#5 | $35M | 631 | 5% | N/A |